RAG2 and teratoma: After intramyocardial transplantation of maGSCs, we found now a reduced frequency and a reduced size of teratomas in T and B-cell-deficient RAG2−/− recipients compared to additionally NK cell-deficient RAG2−/−γc−/− mice.